RGNXNasdaq United States
Market cap
$554.198 M
$10.72 -4.96%
Close of 7 Aug 2026
Revenue
$170.4M
#2354 by revenue
Earnings
-$193.9M
Loss-making
Shares outstanding
66,013,192
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Regenxbio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.